Bruno Rago

Bruno Rago is an accomplished executive in the pharmaceutical industry, currently serving as Vice President of the CNS Franchise and General Manager for Italy at Ethypharm since April 2021. Rago has held multiple high-level positions within Ethypharm, including roles in strategic portfolio management. Prior to this, Rago was the Chief Executive Officer at Avas Pharmaceuticals and served as General Manager for Italy at EUSA Pharma and Jazz Pharmaceuticals, where significant contributions included launching ultra-orphan drugs and leading Italian affiliates. Rago's experience also includes roles at Schering-Plough Research Institute and Organon as Regional Key Account Manager. Educational qualifications include an Executive Formation in Health Technology Assessment from SDA Bocconi and a degree in Biology from the University of Padova.